In summary, this study highlights the importance of S-palmitoylation in regulating the activation and differentiation of TH17 cells through the modulation of STAT3. The reversible nature of this modification allows for tight control of the signalling pathway and provides a potential therapeutic target for diseases associated with TH17 cell overactivation, such as IBD. Additionally, this research sheds light on the broader role of S-palmitoylation in regulating cellular signalling pathways and opens up new avenues for understanding and manipulating these processes.

Here we report that thekey T helper 17 TH17 cell diferentiation stimulator STAT334 is subject to reversibleS-palmitoylation on cysteine 108 DHHC7 palmitoylates STAT3 and promotes itsmembrane recruitme

原文地址: http://www.cveoy.top/t/topic/bD76 著作权归作者所有。请勿转载和采集!

免费AI点我,无需注册和登录